The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial.
 
Yuanming Shen
No Relationships to Disclose
 
Beihua Kong
No Relationships to Disclose
 
Bairong Xia
No Relationships to Disclose
 
Fei Wang
No Relationships to Disclose
 
Rutie Yin
No Relationships to Disclose
 
Qingshui Li
No Relationships to Disclose
 
Ying Yue
No Relationships to Disclose
 
Shan Kang
No Relationships to Disclose
 
Liping He
No Relationships to Disclose
 
Ke Wang
No Relationships to Disclose
 
Yuanguang Meng
No Relationships to Disclose
 
Shixuan Wang
No Relationships to Disclose
 
Pengpeng Qu
No Relationships to Disclose
 
Xianghua Huang
No Relationships to Disclose
 
Ruixia Guo
No Relationships to Disclose
 
Ping Yan
No Relationships to Disclose
 
Mei Pan
No Relationships to Disclose
 
Ge Lou
No Relationships to Disclose
 
Wenjun Cheng
No Relationships to Disclose
 
Xing Xie
No Relationships to Disclose